Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Efficacy of homologous inositol hexaphosphate-loaded red blood cells in sickle transgenic mice.

Bourgeaux V, Aufradet E, Campion Y, De Souza G, Horand F, Bessaad A, Chevrier AM, Canet-Soulas E, Godfrin Y, Martin C.

Br J Haematol. 2012 May;157(3):357-69. doi: 10.1111/j.1365-2141.2012.09077.x. Epub 2012 Mar 7.

PMID:
22404654
2.

Inositol hexaphosphate-loaded red blood cells prevent in vitro sickling.

Bourgeaux V, Hequet O, Campion Y, Delcambre G, Chevrier AM, Rigal D, Godfrin Y.

Transfusion. 2010 Oct;50(10):2176-84. doi: 10.1111/j.1537-2995.2010.02663.x. Epub 2010 Oct 4.

PMID:
20456710
3.

Effect of inositol hexaphosphate-loaded red blood cells (RBCs) on the rheology of sickle RBCs.

Lamarre Y, Bourgeaux V, Pichon A, Hardeman MR, Campion Y, Hardeman-Zijp M, Martin C, Richalet JP, Bernaudin F, Driss F, Godfrin Y, Connes P.

Transfusion. 2013 Mar;53(3):627-36. doi: 10.1111/j.1537-2995.2012.03779.x. Epub 2012 Jul 15.

PMID:
22804873
6.

CXCL1 and its receptor, CXCR2, mediate murine sickle cell vaso-occlusion during hemolytic transfusion reactions.

Jang JE, Hod EA, Spitalnik SL, Frenette PS.

J Clin Invest. 2011 Apr;121(4):1397-401. doi: 10.1172/JCI45336. Epub 2011 Mar 7.

7.

Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.

Pediatrics. 2003 Jun;111(6 Pt 1):e661-5.

PMID:
12777582
8.

Hypoxia-induced acute lung injury in murine models of sickle cell disease.

Pritchard KA Jr, Ou J, Ou Z, Shi Y, Franciosi JP, Signorino P, Kaul S, Ackland-Berglund C, Witte K, Holzhauer S, Mohandas N, Guice KS, Oldham KT, Hillery CA.

Am J Physiol Lung Cell Mol Physiol. 2004 Apr;286(4):L705-14. Epub 2003 Sep 12.

9.

Automated red cell exchange procedures in patients with sickle cell disease.

Kozanoglu I, Boga C, Ozdogu H, Sezgin N, Kizilkilic E, Kural M.

Transfus Apher Sci. 2007 Jun;36(3):305-12. Epub 2007 Jun 20.

PMID:
17584530
10.

Antisickling fetal hemoglobin reduces hypoxia-inducible factor-1α expression in normoxic sickle mice: microvascular implications.

Kaul DK, Fabry ME, Suzuka SM, Zhang X.

Am J Physiol Heart Circ Physiol. 2013 Jan 1;304(1):H42-50. doi: 10.1152/ajpheart.00296.2012. Epub 2012 Nov 2.

11.

Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.

Hendrickson JE, Hod EA, Perry JR, Ghosh S, Chappa P, Adisa O, Kean LS, Ofori-Acquah SF, Archer DR, Spitalnik SL, Zimring JC.

Transfusion. 2012 Feb;52(2):231-40. doi: 10.1111/j.1537-2995.2011.03255.x. Epub 2011 Jul 25.

12.

Hypoxia/reoxygenation stress increases markers of vaso-occlusive crisis in sickle SAD mice.

Aufradet E, DeSouza G, Bourgeaux V, Bessaad A, Campion Y, Canet-Soulas E, Pialoux V, Chirico EN, Chevrier AM, Godfrin Y, Martin C.

Clin Hemorheol Microcirc. 2013 Jan 1;54(3):297-312. doi: 10.3233/CH-131735.

PMID:
23696418
13.

Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy.

Asma S, Kozanoglu I, Tarım E, Sarıturk C, Gereklioglu C, Akdeniz A, Kasar M, Turgut NH, Yeral M, Kandemir F, Boga C, Ozdogu H.

Transfusion. 2015 Jan;55(1):36-44. doi: 10.1111/trf.12780. Epub 2014 Jul 29.

PMID:
25070465
14.

Ultrasound imaging of renal vaso-occlusive events in transgenic sickle mice exposed to hypoxic stress.

Bonnin P, Sabaa N, Flamant M, Debbabi H, Tharaux PL.

Ultrasound Med Biol. 2008 Jul;34(7):1076-84. doi: 10.1016/j.ultrasmedbio.2007.12.003. Epub 2008 Feb 6.

PMID:
18258352
15.

Blood bank issues associated with red cell exchanges in sickle cell disease.

Sarode R, Altuntas F.

J Clin Apher. 2006 Dec;21(4):271-3. Review.

PMID:
17177280
16.

The novel hemoglobin-based oxygen carrier HRC 101 improves survival in murine sickle cell disease.

Crawford MW, Shichor T, Engelhardt T, Adamson G, Bell D, Carmichael FJ, Kim PC.

Anesthesiology. 2007 Aug;107(2):281-7.

PMID:
17667573
17.

Crises in Sickle Cell Disease.

Novelli EM, Gladwin MT.

Chest. 2016 Apr;149(4):1082-93. doi: 10.1016/j.chest.2015.12.016. Epub 2015 Dec 28. Review.

PMID:
26836899
18.

Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation.

de Franceschi L, Baron A, Scarpa A, Adrie C, Janin A, Barbi S, Kister J, Rouyer-Fessard P, Corrocher R, Leboulch P, Beuzard Y.

Blood. 2003 Aug 1;102(3):1087-96. Epub 2003 Apr 10.

19.

Hypoxemia in sickle cell disease: significance and management.

Caboot JB, Allen JL.

Paediatr Respir Rev. 2014 Mar;15(1):17-23. doi: 10.1016/j.prrv.2013.12.004. Epub 2013 Dec 21. Review.

PMID:
24461342
20.

Targeting Mac-1-mediated leukocyte-RBC interactions uncouples the benefits for acute vaso-occlusion and chronic organ damage.

Chen G, Chang J, Zhang D, Pinho S, Jang JE, Frenette PS.

Exp Hematol. 2016 Oct;44(10):940-6. doi: 10.1016/j.exphem.2016.06.252. Epub 2016 Jul 5.

PMID:
27393574

Supplemental Content

Support Center